Asacol found effective in ulcerative colitis, proctitis
Study data show Asacol (Mesalamine) is effective in treating all extents of ulcerative colitis including isolated proctitis. Findings reinforce the benefits of Asacol for ulcerative colitis patients.
– Data from two Phase III clinical trials support that Asacol, an oral, non-steroidal medication that belongs to the class of agents known as 5-aminosalicylic acids (5-ASAs), is an effective and well-tolerated treatment for patients with all extents of ulcerative colitis (UC), including isolated proctitis.